Cover Image
市場調查報告書

以基因為基礎的醫藥品的中國市場

Genome-Based Drug Markets in China

出版商 Asia Market Information & Development 商品編碼 332740
出版日期 內容資訊 英文 240 Pages
訂單完成後即時交付
價格
Back to Top
以基因為基礎的醫藥品的中國市場 Genome-Based Drug Markets in China
出版日期: 2016年03月10日 內容資訊: 英文 240 Pages
簡介

本報告提供中國的以基因為基礎的醫藥品 (Genome-Based Drug) 市場現況與未來預測(過去5∼10年的實際成果值及今後5∼10年的預測值)分析,整體商務環境,及各產品的市場趨勢和其預測,打入市場策略,關係企業一覽等資訊彙整,為您概述為以下內容。

第1章 簡介

  • 分析範圍及手法
  • 摘要整理

第2章 商務環境

  • 經濟形勢
    • 主要的經濟指標
    • 工業生產
    • 人口及人力資源
    • 直接投資
    • 對外貿易
  • 金融、稅務法規
    • 銀行系統和法規
    • 外匯
    • 稅制和關稅

第3章 以基因為基礎的醫藥品產業的評估

  • 以基因為基礎的醫藥品產業結構
  • 市場規模
  • 推動市場成長要素
  • 主要製造商的生產據點、生產量
  • 主要廠商的市場佔有率
  • 人事費用
  • 潛在參與企業
  • 主要外資型企業
  • 技術開發

第4章 以基因為基礎的醫藥品的銷售量與其預測

  • 概要
  • 以基因為基礎的藥品的銷售額與其預測
    • 細胞激素劑
    • 肽激素劑
    • 血栓溶解藥
    • 消炎酵素劑
    • 水溶性受體
    • 黏合分子
    • 核酸藥
    • 其他以基因為基礎的醫藥品
  • 以基因為基礎的醫藥品的進出口
  • 價格趨勢

第5章 以基因為基礎的醫藥品市場展望

  • 以基因為基礎的醫藥品市場展望:概要
  • 政府的法規
  • 醫療保險產業概要
  • 消費者支出趨勢
  • 人口統計趨勢
  • 醫療產業趨勢
  • 醫院及病床數
  • 以基因為基礎的醫藥品的銷售額:各地區
    • 東部
    • 北部
    • 中部
    • 南部
    • 西部

第6章 行銷策略

  • 中國的流通制度
    • 中國的流通系統
    • 以基因為基礎的醫藥品的流通管道
    • 交通、貨物運輸基礎設施
    • 通訊
  • 中國的市場進入
    • 授權合約
    • 專利經營
    • 電子商務
    • 公司和當地經銷商
    • 代表處和中國當地法人
    • 獨資企業

第7章 以基因為基礎的醫藥品製造廠商一覽

  • 以基因為基礎的醫藥品製造商簡介
  • 經銷商及公司
  • 研究機關及產業團體

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 916

China's demand for Genome-Based Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS

  • Genome-Based Drug Industry Structure
  • Market Size
  • Market Growth Drivers
  • Major Producer Facility Locations and Output
  • Market Share of Key Producers
  • Labor Costs
  • Potential Entrants
  • Major Foreign Investments
  • Technology Development

IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS

  • Overview
  • Genome-Based Drug Sales Volumes and Forecasts (Yuan)
  • Cytokines Drug
  • Peptide Hormones Drug
  • Thrombolytic Agents
  • Enzyme Drug
  • Soluble Recepter
  • Adhesion Molecule
  • Nucleic Acid Drug
  • Other Genome-Based Drug
  • Genome-Based Drug Imports and Exports
  • Pricing Trends

V. GENOME-BASED DRUG MARKET OUTLOOKS

  • Genome-Based Drug Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Genome-Based Drug Sales by Region
  • East
  • North
  • Central
  • South
  • West

VI. MARKETING STRATEGIES

  • Distribution System in China
  • China's Distribution System
  • Genome-Based Drug Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. GENOME-BASED DRUG PRODUCER DIRECTORY

  • Genome-Based Drug Producer Profiles
  • Distributors and Trading Companies
  • Research Institutions and Associations

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary
  • Genome-Based Drug Supply and Demand Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
  • Key Commodity Exports from China
  • China's Exports to its Leading Trade Partners
  • Key Commodity Imports into China
  • China's Imports from Its Leading Trade Partners

III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS

  • Major Producer Facility Locations
  • Major Genome-Based Drug Producer Output
  • Market Share of Key Producers
  • Major Foreign Investments

IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS

  • Overview
  • Genome-Based Drug Sales Volumes and forecasts (Yuan)
  • Cytokines Drug
  • Peptide Hormones Drug
  • Thrombolytic Agents
  • Enzyme Drug
  • Soluble Recepter
  • Adhesion Molecule
  • Nucleic Acid Drug
  • Other Genome-Based Drug
  • Genome-Based Drug Imports and Exports
  • Pricing Trends

V. GENOME-BASED DRUG Y MARKET OUTLOOKS

  • Total Genome-Based Drug Consumption by Market
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Genome-Based Drug Sales by Region
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest

LIST OF CHARTS

I. INTRODUCTION

  • Economic Outlook Summary
  • Genome-Based Drug Supply and Demand Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
  • Key Commodity Exports from China
  • China's Exports to its Leading Trade Partners
  • Key Commodity Imports into China
  • China's Imports from Its Leading Trade Partners

III. GENOME-BASED DRUG INDUSTRY ASSESSMENTS

  • Major Producer Facility Locations
  • Major Genome-Based Drug Producer Output
  • Market Share of Key Producers
  • Major Foreign Investments

IV. GENOME-BASED DRUG SALES VOLUMES AND FORECASTS

  • Overview
  • Genome-Based Drug Sales Volumes and forecasts (Yuan)
  • Cytokines Drug
  • Peptide Hormones Drug
  • Thrombolytic Agents
  • Enzyme Drug
  • Soluble Recepter
  • Adhesion Molecule
  • Nucleic Acid Drug
  • Other Genome-Based Drug
  • Genome-Based Drug Imports and Exports
  • Pricing Trends

V. GENOME-BASED DRUG Y MARKET OUTLOOKS

  • Total Genome-Based Drug Consumption by Market
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Genome-Based Drug Sales by Region
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
Back to Top